NRXP - NRX Pharmaceuticals, Inc. Latest Stock News Market Updates - StockTitan
Slightly above 715827949 percent of NRX Pharmaceuticals' retail investors are aggressively looking to sell. The analysis of the overall investor sentiment regarding NRX Pharmaceuticals suggests that quite a large number of traders are panicking. NRX Pharmaceuticals' investing sentiment overview a quick insight into current market opportunities from investing in NRX Pharmaceuticals. Many technical investors use NRX Pharmaceuticals stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
NRX |
NRXP - NRX Pharmaceuticals, Inc. Latest Stock News Market Updates StockTitan
Read at news.google.com
 |
NRX Pharmaceuticals Fundamental Analysis
We analyze NRX Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of NRX Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of NRX Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Cash Per Share
Cash Per Share Comparative Analysis
NRX Pharmaceuticals is currently under evaluation in cash per share category among its peers. Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.
NRX Pharmaceuticals Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with NRX Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of NRX Pharmaceuticals could also be used in its relative valuation, which is a method of valuing NRX Pharmaceuticals by comparing valuation metrics with similar companies.
Peers
NRX Pharmaceuticals Related Equities
| QNRX | Quoin Pharmaceuticals | 28.12 | ||||
| RNXT | RenovoRx | 5.83 | ||||
| LGVN | Longeveron LLC | 2.43 | ||||
| ADTX | Aditxt | 2.70 | ||||
| CING | Cingulate | 3.02 | ||||
| VRAX | Virax Biolabs | 4.62 | ||||
| NTRB | Nutriband | 9.01 | ||||
| PHGE | Biomx | 13.70 | ||||
| SNTI | Senti Biosciences | 28.60 |
Additional Tools for NRX Stock Analysis
When running NRX Pharmaceuticals' price analysis, check to measure NRX Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NRX Pharmaceuticals is operating at the current time. Most of NRX Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of NRX Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NRX Pharmaceuticals' price. Additionally, you may evaluate how the addition of NRX Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.